特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

糖鎖生物学の世界市場:2025年までの予測と市場機会

Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 934749
出版日 ページ情報 英文 116 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

糖鎖生物学の世界市場:2025年までの予測と市場機会 Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025
出版日: 2020年05月01日 ページ情報: 英文 116 Pages
概要

世界の糖鎖生物学市場は、予測期間中に目覚ましい速度で成長すると予想されます。 世界の糖鎖生物学市場は、癌、糖尿病、腎疾患などの慢性疾患の有病率の増加に牽引されており、個別化医療の需要が高まっています。これにより、世界中の創薬プロセスが増加し、予測期間中の市場の成長にプラスの影響を与えると予想されています。

当レポートは、世界の糖鎖生物学市場をセグメント別や地域別で調査したもので、市場規模および市場シェアの予測、促進要因と課題、市場動向、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 COVID-19が世界の糖鎖生物学市場に与える影響

第4章 エグゼクティブサマリー

第5章 顧客の声

  • ブランド認知度
  • 製品認識
  • 顧客満足度の分析
  • 満たされていないニーズや課題

第6章 世界の糖鎖生物学市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 酵素の種類別(グリコシダーゼとノイラミダーゼ、グリコシルトランスフェラーゼとシアルトランスフェラーゼ、炭水化物キナーゼ、炭水化物スルホトランスフェラーゼ、タンパク質スルホトランスフェラーゼ、その他)
    • キットの種類別(グリカンリリースキット、グリカンラベリングキット、グリカン精製キット、その他)
    • 用途別(創薬、疾患診断、ウイルス学、細胞生物学、腫瘍学、その他)
    • エンドユーザー別(調査機関、診断センター、病院、臨床研究所、製薬・バイオテクノロジー企業、その他)
    • 会社別(2019年)
    • 地域別
  • 製品市場マップ

第7章 アジア太平洋の糖鎖生物学の市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 酵素の種類別
    • キットの種類別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第8章 欧州の糖鎖生物学市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 酵素の種類別
    • キットの種類別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州:国分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 北米の糖鎖生物学市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 酵素の種類別
    • キットのタイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米:国分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米の糖鎖生物学の市場展望

  • 市場規模と予測
  • 市場シェアと予測
    • 酵素の種類別
    • キットの種類別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米:国分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの糖鎖生物学市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 酵素の種類別
    • キットの種類別
    • 用途別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ:国分析
    • 南アフリカ
    • サウジアラビア
    • UAE
    • クウェート

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

第14章 競合情勢

  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • New England Biolabs, Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Asparia Glycomics S.L.
  • Bruker Corporation
  • RayBiotech, Inc.
  • Z Biotech, LLC.
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Lectenz Bio
  • Ludger Ltd
  • R&D Systems, Inc.
  • Bio-Techne
  • Danaher Corporation
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • ProZyme

第15章 戦略的推奨事項

第16章 免責事項

目次
Product Code: 4635

Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of market over the next few years.

The global glycobiology market is segmented based on type of enzyme, type of kit, application, end user, company and region. Based on type of enzyme, the market can be categorized into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is expected to dominate the market during the forecast period. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.

Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast period in the overall glycobiology market owing to the presence of many research laboratories and pharmaceutical and biotechnology companies in the region.

Major players operating in the global glycobiology market include Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), ProZyme and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2018, Shimadzu Corp. collaborated with premier Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global glycobiology market from 2015 to 2018.
  • To estimate and forecast the market size of global glycobiology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global glycobiology market based on type of enzyme, type of kit, application, end user, company and regional distribution.
  • To identify dominant region or segment in the global glycobiology market.
  • To identify drivers and challenges for global glycobiology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global glycobiology market.
  • To identify and analyze the profile of leading players operating in global glycobiology market.
  • To identify key sustainable strategies adopted by market players in global glycobiology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers of enzymes, kits & instruments used in glycobiology technique across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers of enzymes, kits & instruments used in glycobiology techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers of enzymes, kits & instruments used in glycobiology techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global glycobiology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Glycobiology enzymes, kits & instruments, manufacturers, suppliers, distributorsand other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to glycobiology
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers of enzymes, kits & instruments used in glycobiology techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global glycobiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Glycobiology Market, By Type of Enzyme:

Glycosidases & Neuramidases

Glycosyltransferases & Sialytransferases

Carbohydrate Kinases

Carbohydrate Sulfotransferases

Protein Sulfotransferases

Others

  • Global Glycobiology Market, By Type of Kit:

Glycan Releasing Kit

Glycan Labelling Kit

Glycan Purification Kit

Others

  • Global Glycobiology Market, By Application:

Drug Discovery

Disease Diagnostics

Virology

Cell Biology

Oncology

Others

  • Global Glycobiology Market, By End User:

Research Institutes

Diagnostic Centers

Hospitals

Clinical Laboratories

Pharmaceutical & Biotechnology Companies

Others

  • Global Glycobiology Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global glycobiology market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Unmet Needs/Challenges

6. Global Glycobiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
    • 6.2.2. By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
    • 6.2.3. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
    • 6.2.4. By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Glycobiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Enzyme
    • 7.2.2. By Type of Kit
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Glycobiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Enzyme
        • 7.3.1.2.2. By Type of Kit
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. India Glycobiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Enzyme
        • 7.3.2.2.2. By Type of Kit
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Glycobiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Enzyme
        • 7.3.3.2.2. By Type of Kit
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Glycobiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Enzyme
        • 7.3.4.2.2. By Type of Kit
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Glycobiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Enzyme
        • 7.3.5.2.2. By Type of Kit
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Europe Glycobiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Enzyme
    • 8.2.2. By Type of Kit
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Glycobiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Enzyme
        • 8.3.1.2.2. By Type of Kit
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Glycobiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Enzyme
        • 8.3.2.2.2. By Type of Kit
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Glycobiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Enzyme
        • 8.3.3.2.2. By Type of Kit
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Glycobiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Enzyme
        • 8.3.4.2.2. By Type of Kit
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Glycobiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Enzyme
        • 8.3.5.2.2. By Type of Kit
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. North America Glycobiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Enzyme
    • 9.2.2. By Type of Kit
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Glycobiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Enzyme
        • 9.3.1.2.2. By Type of Kit
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Glycobiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Enzyme
        • 9.3.2.2.2. By Type of Kit
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Glycobiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Enzyme
        • 9.3.3.2.2. By Type of Kit
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Glycobiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Enzyme
    • 10.2.2. By Type of Kit
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Glycobiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Enzyme
        • 10.3.1.2.2. By Type of Kit
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Glycobiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Enzyme
        • 10.3.2.2.2. By Type of Kit
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Glycobiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Enzyme
        • 10.3.3.2.2. By Type of Kit
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Glycobiology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type of Enzyme
    • 11.2.2. By Type of Kit
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Glycobiology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type of Enzyme
        • 11.3.1.2.2. By Type of Kit
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Glycobiology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type of Enzyme
        • 11.3.2.2.2. By Type of Kit
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Glycobiology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type of Enzyme
        • 11.3.3.2.2. By Type of Kit
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Kuwait Glycobiology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type of Enzyme
        • 11.3.4.2.2. By Type of Kit
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Merck & Co., Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Thermo Fisher Scientific
  • 14.4. New England Biolabs, Inc.
  • 14.5. Shimadzu Corporation
  • 14.6. Takara Bio Inc.
  • 14.7. Waters Corporation
  • 14.8. Asparia Glycomics S.L.
  • 14.9. Bruker Corporation
  • 14.10. RayBiotech, Inc.
  • 14.11. Z Biotech, LLC.
  • 14.12. Chemily Glycoscience
  • 14.13. Dextra Laboratories Ltd.
  • 14.14. Lectenz Bio
  • 14.15. Ludger Ltd
  • 14.16. R&D Systems, Inc.
  • 14.17. Bio-Techne
  • 14.18. Danaher Corporation
  • 14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • 14.20. ProZyme

15. Strategic Recommendations

16. About Us & Disclaimer